Tricuspid atresia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
===ACC/AHA 2008 Guidelines - Recommendations for Endocarditis Prophylaxis - Tricuspid atresia (DO NOT EDIT)=== | ===ACC/AHA 2008 Guidelines - Recommendations for Endocarditis Prophylaxis - Tricuspid atresia (DO NOT EDIT)=== | ||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] | |||
|- | |||
| bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.'''Prophylaxis against IE is not recommended for nondental procedures (such as esophagogastroduodenoscopy or colonoscopy) in the absence of active infection.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" | {|class="wikitable" | ||
| Line 31: | Line 38: | ||
|- | |- | ||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''b.'''Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | | bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''b.'''Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|} | |} | ||
Revision as of 17:27, 12 October 2012
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia secondary prevention |
|
Risk calculators and risk factors for Tricuspid atresia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [[3]]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Secondary Prevention
ACC/AHA 2008 Guidelines - Recommendations for Endocarditis Prophylaxis - Tricuspid atresia (DO NOT EDIT)
| Class III |
| "1.Prophylaxis against IE is not recommended for nondental procedures (such as esophagogastroduodenoscopy or colonoscopy) in the absence of active infection.(Level of Evidence: C) " |
| Class IIa |
| "1.Antibiotic prophylaxis before dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa is reasonable in those patients with the following indications: " |
| "a.Prosthetic cardiac valve.(Level of Evidence: B)" |
| "b.Previous infective endocarditis (IE).(Level of Evidence: B)" |
| "c.Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits.(Level of Evidence: B)" |
| "d.Completely repaired CHD with prosthetic materials, whether placed by surgery or catheter intervention, during the first 6 months after the procedure.(Level of Evidence: B)" |
| "e.Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device that inhibit endothelialization.(Level of Evidence: B)" |
| "2.It is reasonable to consider antibiotic prophylaxis against IE before vaginal delivery at the time of membrane rupture in select patients with the highest risk of adverse outcomes. This includes patients with the following indications:" |
| "a.Prosthetic cardiac valve or prosthetic material used for cardiac valve repair.(Level of Evidence: C)" |
| "b.Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits.(Level of Evidence: C)" |